StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$124.86−0.78 (-0.62%)

Close on Nov 18, 2026Market cap $5.22BP/E –Yield –

Veradermics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Veradermics's shares outstanding was 40M at Jun 30, 2026. For fiscal 2025 it was 1M, up 1.1% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+1.1%
FY2024Dec 31, 20241M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202640M–
Q1 FY2026Mar 31, 202623M–
Q2 FY2025Jun 30, 20251M–
Q1 FY2025Mar 31, 20251M–

More Veradermics figures

See a number that looks wrong?